NCT06208527View on ClinicalTrials.gov

The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions
FrailtyFrail Elderly SyndromeFrailty SyndromeAging
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside (NR)

A total of 2000 mg NR is administered daily for 1 year.

OTHER

Placebo

Placebo tablet identical in taste, shape and appearance to NR tablets.

Trial Locations (2)

5021

NOT_YET_RECRUITING

Haukeland University Hospital, Bergen

RECRUITING

Haukeland University Hospital, Bergen

All Listed Sponsors
lead

Haukeland University Hospital

OTHER